EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis - Phase 3 protocol submitted with FDA feedback expected imminently; incremental data submitted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results